Conference Coverage

Conference Coverage

JAK inhibitors for RA: Is VTE risk overblown?

MAUI, HAWAII – “Certainly we are seeing these events. The question is, ‘How overdone is this?’ ” said Mark C. Genovese, MD.

Pages